Abstract

BackgroundBoth tissue sealants and buttressing have been advocated to reduce alveolar air leaks from staple lines following Lung Volume Reduction Surgery (LVRS). However, the long term detrimental effects of buttressing material are increasingly apparent. We performed a pilot prospective randomised self controlled trial in patients undergoing LVRS comparing BioGlue and Peri-strips as adjuncts in preventing alveolar air-leaks.MethodsA pilot prospective self controlled clinical trial was conducted in patients undergoing LVRS. Each patient was treated with BioGlue on one side and pericardial buttress on the other side as an adjunct to the staple line. The sides were randomised for adjuncts with each patient acting as his own control. Duration of air leak, intercostal drainage and time to chest drain removal were the study end points.Results10 patients undergoing the procedure were recruited between December 2005 and October 2007. There were 6 men and the mean age was 59.8 ± 4.9 years. There was one mortality due to multi-organ failure. The BioGlue treated side had a shorter mean duration of air-leak (3.0 ± 4.6 versus 6.5 ± 6.9 days), lesser chest drainage volume (733 ± 404 ml versus 1001 ± 861) and shorter time to chest drain removal (9.7 ± 10.6 versus 11.5 ± 11.1 days) compared with Peri-strips.ConclusionThis study demonstrates comparable efficacy of BioGlue and Peri-strips, however there is a trend favouring the BioGlue treated side in terms of reduction in air-leak, chest drainage volumes, duration of chest drainage and significant absence of complications. A larger sample size is needed to validate this result.

Highlights

  • Lung Volume Reduction Surgery (LVRS) benefits a selected group of patients with end stage emphysema [1,2]

  • Patients undergoing bilateral LVRS through a median sternotomy incision were included in the study

  • All patients had routine work-up for LVRS according to our unit protocol, comprising full lung function tests, high resolution CT scanning (HRCT), quantitative ventilation-perfusion scanning, echocardiography in patients with previous cardiac history, smoking cessation and pulmonary rehabilitation

Read more

Summary

Introduction

Lung Volume Reduction Surgery (LVRS) benefits a selected group of patients with end stage emphysema [1,2]. BioGlue surgical sealant (CryoLife Inc. Kennesaw, U.S.A) is a topically applied mixture of bovine serum albumin and glutaraldehyde. U.S.A) is a topically applied mixture of bovine serum albumin and glutaraldehyde It is approved for use as an adjunct to standard methods of haemostasis and for use in a wide range of soft tissue repairs. At present there are no published reports regarding the utility or efficacy of BioGlue in LVRS patients. Both tissue sealants and buttressing have been advocated to reduce alveolar air leaks from staple lines following Lung Volume Reduction Surgery (LVRS). We performed a pilot prospective randomised self controlled trial in patients undergoing LVRS comparing BioGlue and Peri-strips as adjuncts in preventing alveolar air-leaks

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call